Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT07220902
Eligibility Criteria:
Inclusion Criteria:
* Pregnant or postpartum women aged 19 years or older
* Diagnosed with preeclampsia with severe features, superimposed preeclampsia or HELLP syndrome
* At risk for eclampsia and eligible for seizure prophylaxis
* Less than 2 hours exposure to magnesium sulfate or greater than 48 hours since last dose.
* Admitted or plan to proceed with delivery
Exclusion Criteria:
* \<32 weeks estimated gestational age
* History of epilepsy or seizure disorders unrelated to pregnancy
* Allergy or contraindication to Levetiracetam or Magnesium Sulfate
* Severe renal impairment (Oliguria \<120ml in 4 hours)
* Plan for neonatal comfort care
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
19 Years
Study:
NCT07220902
Study Brief:
Protocol Section:
NCT07220902